Duality Biotherapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	May '26 May 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	20,165	26,664	-	-
Enterprise Value	16,571	22,676	-	-
Last Close Price	223.00	298.20	-	-
PS Ratio	9.79	12.94	-	-
PB Ratio	7.47	9.87	-	-
P/TBV Ratio	7.48	9.89	-	-
P/FCF Ratio	98.98	130.88	-	-
P/OCF Ratio	93.13	123.14	-	-
EV/Sales Ratio	8.04	11.00	-	-
EV/FCF Ratio	81.33	111.30	-	-
Debt / Equity Ratio	0.06	0.06	0.00	0.00
Debt / EBITDA Ratio	-	-	-	0.01
Debt / FCF Ratio	0.82	0.82	0.02	0.01
Net Debt / Equity Ratio	-1.33	-1.33	0.69	1.01
Net Debt / EBITDA Ratio	7.14	7.14	7.63	-1.53
Net Debt / FCF Ratio	-17.64	-17.64	-4.94	-1.40
Asset Turnover	0.62	0.62	1.08	-
Quick Ratio	3.52	3.52	0.48	0.50
Current Ratio	3.65	3.65	0.49	0.52
Return on Equity (ROE)	-1282.14%	-1282.14%	-	-
Return on Assets (ROA)	-9.61%	-9.61%	-6.51%	-
Return on Capital Employed (ROCE)	-16.20%	-16.20%	10.50%	-69.40%
Earnings Yield	-14.32%	-10.83%	-	-
FCF Yield	1.01%	0.76%	-	-
Buyback Yield / Dilution	-714.45%	-714.45%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.